| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Strategic Planning > 9 Good Questions to Ask When Selling Your Practice |
|
Just Other Articles - 9 Good Questions to Ask When Selling Your Practice
1. Is my Practice ready? 2. Am I ready? 3. What aspects add to/detract from the value of the sale price of According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product my business? 4. Would my key staff stay or leave if I do? 5. How long will it take to sell my practice? 6. ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in How do I find the right buyer for my business? 7. How long am I prepared to stay in the business once it is lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. sold ?(trade out period) 8. What is the opportunity cost of selling now vs later 9. How can I manage and m here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe nimise my risks while selling the business If you are not clear on the answers to all the questions above, < d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro a target="_new" href="http://www.clarityinbusiness.com">CLARITY can help.
Through our customised consult ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ing service, we can assist you to transition and prepare for the sale of your Practice, to maximise your resu easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi lts. As a minimum, we typically work with you in the following ways: - Work with you to establish how, when nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically nd under what conditions you would sell your business. - Help you to omake your business ready for sale, in and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ a manner that maximises its potential value and sale price, and attracts the largest number of prospective bu ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi yers. - Actively identify, attract, and screen, to find the right associates or buyers from the UK, NZ or Au ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a stralia. - Assist you to develop appropriate marketing material for the sale of your business if required. dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod Ensure you have access to the best commercial advice regarding legal, contractual, operational, and other re cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin quirements neccessary for the sale of the Practice, and - Provide assistance and guidelines for a smooth ori tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen entation and induction of associates or other new staff if required. And if you are planning to relocate to t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel another country, CLARITY can also help you sell your Practice in one country, eg UK, Australia, New Zealand o ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust Canada, and to find a suitable Practice in another country. Where needed, we work with expert third party se y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products rvice providers to ensure all your legal, financial and practical requirements are handled by service provide . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de rs with international expertise. CLARITY see this as a true partnership process, and look forward to sharing elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip the champagne with you when your business is sold for a much better price than would otherwise be attainable tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:What Are The Common Types Of Marketing Jobs? Sales Managers: Post Your Sales Results Conspicuously!
|